Principles of Transparency and Best Practice
1. Website
The URL of official journal web site is https://www.medpharmres.com.
The editorial team endeavors to make a good website. Our website demonstrates that care has been taken to ensure high ethical and professional standards. It does not contain any misleading information, including any attempt to mimic another journal/publisher’s site.
2. Name of Journal
The official journal title is MedPharmRes (herein “MPR”), the abbreviation of ISO is MedPharmRes.
3. Peer Review Process
The MPR has on online submission and peer review system at https://www.editorialmanager.com/medpharmres.
MPR adopts single-blind peer review and reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool.
The manuscripts are sent to two or more most relevant investigators for review of the contents. The editor selects peer referees by recommendation of the Editorial Board members or from the specialist database owned by the Editorial Board. The peer review process takes usually 4 to 8 weeks after the manuscript submission.
4. Ownership and Management
This journal is owned by the publisher, the University of Medicine and Pharmacy at Ho Chi Minh City (UMP).
5 Governing Body
The governing body is the journal's editorial board.
6. Editorial Team and Contact Information
The full names and affiliations of the journal’s editors and members of journal management team are displayed on the Journal Info (Editorial board) tab of journal homepage, and the contact information for the editorial office is on the Journal Info (Contact information) tab.
7. Copyright and Licensing
Copyright to all published materials is owned by the University of Medicine and Pharmacy at Ho Chi Minh City (UMP). All authors should agree to the copyright transfer during the submission process.
MPR is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To use the tables or figures of MPR in other journals, books or media for scholarly, educational purposes, the process of permission request to the publisher is not necessary. All contents of the journal are available immediately upon publication without embargo period.
8. Author Fees
With the support of the open access Article-Processing Charge (APC), MedPharmRes enables authors to have their final version of their papers published on an open access basis, granting on publication, immediate and unrestricted access to the final published version of the paper. This is made available using the Creative Commons Attribution (CC BY-NC) licence.
Authors publish in MedPharmRes with a full waiver of APC until the second trimester of 2024.
9. Process for Identification of and Dealing with Allegations of Research Misconduct
When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.
10. Publication Ethics
MPR follows the Guideline on Good Publication of COPE (https://publicationethics.org).
Our publication ethics are displayed on the For Authors (Research and Publication Ethic) tab of journal homepage.
11. Publishing Schedule
MPR is published 4 times (March 31, June 30, September 30, and December 31) a year.
12. Access
MPR is an open access journal. A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.
13. Archiving
It is accessible without barrier from the journal homepage.
Authors cannot archive pre-print (i.e., pre-refereeing), and they can archive post-print (i.e., final draft post-refereeing). Authors can archive publisher’s version/PDF.
14. Revenues sources
Revenue sources of journal are from the support of publisher (University of Medicine and Pharmacy at Ho Chi Minh City), author fees, and advertising rates.
15. Advertising
MPR does not accept any commercial product advertisements until policy changes otherwise.
16. Direct Marketing
Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.